( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
84167.1
78982.1
74913.8
72668
Total Expenditure
25969
25540.2
24604.3
22863.2
PBIDT (Excl OI)
58198.1
53441.9
50309.5
49804.8
Other Income
1468.3
1104.7
1220.4
862.9
Operating Profit
59666.4
54546.6
51529.9
50667.7
Interest
37530.2
36457.4
35173.1
34680.6
Exceptional Items
NA
NA
NA
NA
PBDT
22136.2
18089.2
16356.8
15987.1
Depreciation
716.4
737.8
710.3
674.4
Profit Before Tax
21419.8
17351.4
15646.5
15312.7
Tax
4979.2
4457.7
4063
3941.7
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
16440.6
12893.7
11583.5
11371
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
16440.6
12893.7
11583.5
11371
Minority Interest
NA
NA
NA
NA
Shares of Associates
11.4
6
12.6
7.3
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
16452
12899.7
11596.1
11378.3
Equity Capital
1704.8
1688.6
1683.5
1683
Calculated EPS
19.30
15.27
13.77
13.52
Calculated EPS (Annualised)
77.20
61.11
55.10
54.08
No of Public Share Holdings
432397124
424312426
421719487
421415122
% of Public Share Holdings
50.75
50.28
50.12
50.1
PBIDTM% (Excl OI)
69.14
67.66
67.15
68.53
PBIDTM%
70.89
69.06
68.78
69.72
PBDTM%
26.30
22.90
21.83
22.00
PBTM%
25.44
21.96
20.88
21.07
PATM%
19.53
16.32
15.46
15.64